List of bibliographic references
Number of relevant bibliographic references: 11.
List of associated KwdEn.i
Nombre de documents | Descripteur |
10 | Humans |
7 | Animals |
6 | Female |
6 | Mice |
5 | Radioimmunotherapy (methods) |
4 | Mice, Nude |
4 | Thyroid Neoplasms (radiotherapy) |
3 | Adult |
3 | Aged |
3 | Cell Line, Tumor |
3 | Iodine Radioisotopes (therapeutic use) |
3 | Male |
3 | Middle Aged |
3 | Neoplasm Metastasis |
3 | Radioimmunotherapy |
3 | Receptors, Neurotensin (metabolism) |
3 | Tissue Distribution |
2 | Antibodies, Bispecific (adverse effects) |
2 | Carcinoembryonic Antigen (immunology) |
2 | Combined Modality Therapy |
2 | Indium Radioisotopes (diagnostic use) |
2 | Indium Radioisotopes (pharmacokinetics) |
2 | Mice, Inbred BALB C |
2 | Neoplasms (diagnosis) |
2 | Neoplasms (metabolism) |
2 | Neoplasms (radionuclide imaging) |
2 | Pentetic Acid (pharmacokinetics) |
2 | Prognosis |
2 | Radioimmunotherapy (adverse effects) |
2 | Survival Analysis |
2 | Thyroid Neoplasms (diagnosis) |
2 | Thyroid Neoplasms (pathology) |
2 | Treatment Outcome |
2 | Tumor Cells, Cultured |
1 | Adenocarcinoma (diagnosis) |
1 | Adenocarcinoma (metabolism) |
1 | Aged, 80 and over |
1 | Amino Acid Sequence |
1 | Antibodies (blood) |
1 | Antibodies (immunology) |
1 | Antibodies (therapeutic use) |
1 | Antibodies, Bispecific |
1 | Antibodies, Bispecific (administration & dosage) |
1 | Antibodies, Bispecific (chemistry) |
1 | Antibodies, Bispecific (immunology) |
1 | Antibodies, Bispecific (pharmacokinetics) |
1 | Antibodies, Bispecific (therapeutic use) |
1 | Antibodies, Monoclonal (administration & dosage) |
1 | Antibodies, Monoclonal (adverse effects) |
1 | Antibodies, Monoclonal (therapeutic use) |
1 | Antibodies, Monoclonal, Humanized (adverse effects) |
1 | Antibodies, Monoclonal, Humanized (therapeutic use) |
1 | Antibody Specificity |
1 | Antigens, Neoplasm (immunology) |
1 | Avidin (administration & dosage) |
1 | Bone Marrow (pathology) |
1 | Breast Neoplasms (diagnosis) |
1 | Breast Neoplasms (metabolism) |
1 | Calcitonin (blood) |
1 | Carcinoembryonic Antigen (blood) |
1 | Carcinoembryonic Antigen (chemistry) |
1 | Carcinoembryonic Antigen (metabolism) |
1 | Carcinoembryonic Antigen (therapeutic use) |
1 | Carcinoma (metabolism) |
1 | Carcinoma (radiotherapy) |
1 | Carcinoma, Medullary (pathology) |
1 | Carcinoma, Medullary (therapy) |
1 | Colonic Neoplasms (metabolism) |
1 | Colonic Neoplasms (radiotherapy) |
1 | Computer Simulation |
1 | Disease Progression |
1 | Dose Fractionation |
1 | Doxorubicin (therapeutic use) |
1 | Drug Combinations |
1 | Drug Delivery Systems (methods) |
1 | Gallium Radioisotopes (chemistry) |
1 | Gallium Radioisotopes (diagnostic use) |
1 | Haptens (administration & dosage) |
1 | Haptens (adverse effects) |
1 | Haptens (chemistry) |
1 | Haptens (diagnostic use) |
1 | Haptens (metabolism) |
1 | Haptens (therapeutic use) |
1 | Heterocyclic Compounds, 1-Ring (chemistry) |
1 | Heterocyclic Compounds, 1-Ring (diagnostic use) |
1 | Immunoglobulin G (therapeutic use) |
1 | Indium (therapeutic use) |
1 | Indium Radioisotopes (chemistry) |
1 | Indium Radioisotopes (metabolism) |
1 | Iodine Radioisotopes (administration & dosage) |
1 | Iodine Radioisotopes (adverse effects) |
1 | Iodine Radioisotopes (pharmacokinetics) |
1 | Kinetics |
1 | Ligands |
1 | Metabolic Clearance Rate (drug effects) |
1 | Neoplasm Transplantation |
1 | Neoplasms (radiotherapy) |
1 | Neoplasms (therapy) |
1 | Neoplasms, Experimental |
1 | Neurotensin (analogs & derivatives) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Jacques Barbet"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Jacques Barbet" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Jacques Barbet
}}
| This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024 |  |